Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 0.224M
March 31, 2026 -0.088M
December 31, 2025 -0.037M
September 30, 2025 0.268M
June 30, 2025 0.072M
March 31, 2025 -0.052M
December 31, 2024 -0.087M
September 30, 2024 15.37M
June 30, 2024 -0.022M
March 31, 2024 -0.343M
December 31, 2023 -0.598M
September 30, 2023 13.65M
June 30, 2023 -0.18M
Date Value
March 31, 2023 -0.025M
December 31, 2022 5.14M
September 30, 2022 0.035M
June 30, 2022 5.037M
March 31, 2022 0.055M
December 31, 2021 -0.001M
September 30, 2021 -1.265M
June 30, 2021 101.78M
March 31, 2021 10.28M
December 31, 2020 0.00
September 30, 2020 -1.554M
June 30, 2020 0.00
March 31, 2020 -0.045M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
MetaStat, Inc. --
Lifecore Biomedical, Inc. -0.852M
Repligen Corp. -6.20M
Bio-Techne Corp. -33.21M
Codexis, Inc. 0.066M